Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells.

[1]  P. Darbre,et al.  Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF7 human breast cancer cells , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Neil J McKenna,et al.  GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells. , 2009, Cancer research.

[3]  Trevor M Penning,et al.  Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels. , 2008, Chemical research in toxicology.

[4]  T. Yeatman,et al.  Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. , 2008, Cancer research.

[5]  E. Winer,et al.  Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer , 2008, Cancer.

[6]  L. Kaminsky,et al.  Induction of CYP1A1 and CYP1B1 by benzo(k)fluoranthene and benzo(a)pyrene in T-47D human breast cancer cells: roles of PAH interactions and PAH metabolites. , 2008, Toxicology and applied pharmacology.

[7]  B. Wittmann,et al.  Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators. , 2007, Cancer research.

[8]  Johan Staaf,et al.  High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization , 2007, Genes, chromosomes & cancer.

[9]  V. Jordan.  SERMs: meeting the promise of multifunctional medicines. , 2007, Journal of the National Cancer Institute.

[10]  T. Walle,et al.  Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. , 2007, Cancer letters.

[11]  V. Jordan,et al.  Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer , 2007, Steroids.

[12]  H. Earl,et al.  Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. , 2007, Journal of the National Cancer Institute.

[13]  H. Schut,et al.  Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry. , 2007, Chemical research in toxicology.

[14]  Graham A Colditz,et al.  Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. , 2006, Journal of the National Cancer Institute.

[15]  Olivier Humblet,et al.  Environmental pollutants and breast cancer: epidemiologic studies. , 2007, Cancer.

[16]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[17]  D. Spiegelman,et al.  Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. , 2006, Journal of the National Cancer Institute.

[18]  G. Orphanides,et al.  Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation , 2006, Molecular and Cellular Endocrinology.

[19]  Norman Wolmark,et al.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.

[20]  S. Verma,et al.  Pre-menopausal breast cancer and aromatase inhibitors: treating a new generation of women , 2006, Breast Cancer Research and Treatment.

[21]  T. Kanzaki,et al.  Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women. , 2006, Maturitas.

[22]  S. Sheriff,et al.  Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. , 2006, Cancer research.

[23]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[24]  H. Jacobson,et al.  AFPep: an anti-breast cancer peptide that is orally active , 2006, Breast Cancer Research and Treatment.

[25]  M. Gleave,et al.  Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo , 2005, Molecular Cancer Therapeutics.

[26]  L. Ford,et al.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.

[27]  B. Lee,et al.  Effect of estrogen receptor (ER) on benzo[a]pyrene-DNA adduct formation in human breast cancer cells. , 2005, Journal of toxicology and environmental health. Part A.

[28]  E. Lobenhofer,et al.  Adaptation of Estrogen-regulated Genes in Long-term Estradiol Deprived MCF-7 Breast Cancer Cells , 2005, Breast Cancer Research and Treatment.

[29]  Robert B Livingston,et al.  Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. , 2005, Journal of the National Cancer Institute.

[30]  S. J. Culp,et al.  High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts. , 2005, Chemical research in toxicology.

[31]  H. Håkansson,et al.  Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  E. Musgrove,et al.  Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF‐7 human breast cancer cells , 2005, Journal of cellular physiology.

[33]  L. Kaminsky,et al.  MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS , 2005, Drug Metabolism and Disposition.

[34]  Bert W O'Malley,et al.  Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Shinzaburo Noguchi,et al.  mRNA expression level of estrogen‐inducible gene, α1‐antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers , 2004, Cancer science.

[36]  M. Eren,et al.  Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor &agr; and Estrogen Receptor &bgr; in Endothelial Cells , 2004, Circulation research.

[37]  John H. White,et al.  Genome-wide identification of high-affinity estrogen response elements in human and mouse. , 2004, Molecular endocrinology.

[38]  R. Kiyama,et al.  Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. , 2004, Journal of molecular endocrinology.

[39]  S. Nesnow,et al.  Identification and characterization of novel stable deoxyguanosine and deoxyadenosine adducts of benzo[a]pyrene-7,8-quinone from reactions at physiological pH. , 2004, Chemical research in toxicology.

[40]  C. Nguyen,et al.  Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. , 2004, Journal of molecular endocrinology.

[41]  S. Safe,et al.  Mechanisms of Inhibitory Aryl Hydrocarbon Receptor-Estrogen Receptor Crosstalk in Human Breast Cancer Cells , 2000, Journal of Mammary Gland Biology and Neoplasia.

[42]  D. Spink,et al.  Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. , 2003, Biochemical pharmacology.

[43]  Z. Cao,et al.  Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. , 2003, Carcinogenesis.

[44]  K. Coser,et al.  Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Sven Bilke,et al.  The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. , 2003, Cancer research.

[46]  Barry Komm,et al.  Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. , 2003, Endocrinology.

[47]  F. Matsumura,et al.  Long-term exposure to β-hexachlorocyclohexane (β-HCH) promotes transformation and invasiveness of MCF-7 human breast cancer cells , 2003 .

[48]  Ruthann A Rudel,et al.  Environmental pollutants and breast cancer , 2007, Cancer.

[49]  F. Matsumura,et al.  Long-term exposure to beta-hexachlorocyclohexane (beta-HCH) promotes transformation and invasiveness of MCF-7 human breast cancer cells. , 2003, Biochemical pharmacology.

[50]  Steven C. Lawlor,et al.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data , 2003, Genome Biology.

[51]  B. van der Burg,et al.  Estrogen Receptor (cid:1) -mediated Silencing of Caveolin Gene Expression in Neuronal Cells* , 2002 .

[52]  T. Yamori,et al.  Development of cDNA microarray for expression profiling of estrogen-responsive genes. , 2002, Journal of molecular endocrinology.

[53]  M. Clemons,et al.  Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies. , 2002, The Lancet. Oncology.

[54]  K. Matsushima,et al.  WISP-2 is a secreted protein and can be a marker of estrogen exposure in MCF-7 cells. , 2002, Biochemical and biophysical research communications.

[55]  Steven C. Lawlor,et al.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways , 2002, Nature Genetics.

[56]  Y. Chen,et al.  Ovarian Steroid-Regulated Synthesis and Secretion of Complement C3 and Factor B in Mouse Endometrium During the Natural Estrous Cycle and Pregnancy Period1 , 2002, Biology of reproduction.

[57]  M. Parker,et al.  Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. , 2001, Journal of molecular endocrinology.

[58]  F. Guengerich,et al.  A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. , 2001, Cancer research.

[59]  K. Shinohara,et al.  Effect of estrogen on the expression of Cry1 and Cry2 mRNAs in the suprachiasmatic nucleus of female rats , 2001, Neuroscience Research.

[60]  K. Peltonen,et al.  Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo(a)pyrene and 5-methylchrysene in a human mammary carcinoma cell line (MCF-7) , 2001 .

[61]  J. McLachlan,et al.  Gene imprinting in developmental toxicology: a possible interface between physiology and pathology. , 2001, Toxicology letters.

[62]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[63]  R. Weigel,et al.  PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. , 2000, Cancer research.

[64]  P. Hanawalt,et al.  p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. , 2000, Cancer research.

[65]  R. Pollenz,et al.  Aryl Hydrocarbon Receptor Imported into the Nucleus following Ligand Binding Is Rapidly Degraded via the Cytosplasmic Proteasome following Nuclear Export* , 1999, The Journal of Biological Chemistry.

[66]  I. Blair,et al.  Synthesis and characterization of polycyclic aromatic hydrocarbon o-quinone depurinating N7-guanine adducts. , 1999, Chemical research in toxicology.

[67]  T. Sutter,et al.  Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. , 1998, Carcinogenesis.

[68]  B. Pentecost.  Expression and estrogen regulation of the HEM45 mRNA in human tumor lines and in the rat uterus , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[69]  E. Cavalieri,et al.  Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. , 1996, Chemical research in toxicology.

[70]  H. Yamazaki,et al.  Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. , 1996, Cancer research.

[71]  P. Basset,et al.  Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co‐localization to human chromosome 1q21‐q22 , 1995, International journal of cancer.

[72]  N. Normanno,et al.  Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. , 1995, Endocrinology.

[73]  M. Rämet,et al.  p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. , 1995, Carcinogenesis.

[74]  N. Normanno,et al.  Expression of transforming growth factor α antisense mRNA inhibits the estrogen‐induced production of TGFα and estrogen‐induced proliferation of estrogen‐responsive human breast cancer cells , 1993 .

[75]  P. Chambon,et al.  Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma. , 1993, Cancer research.

[76]  S. Lye,et al.  Regulation of transcripts encoding the myometrial gap junction protein, connexin-43, by estrogen and progesterone. , 1993, Endocrinology.

[77]  M. Linder,et al.  Synthesis and Turnover of Ceruloplasmin in Rats Treated with 17β-Estradiol , 1993 .

[78]  M. Sheikh,et al.  Differential regulation of matrix Gla protein (MGP) gene expression by retinoic acid and estrogen in human breast carcinoma cells , 1993, Molecular and Cellular Endocrinology.

[79]  J. Lay,et al.  Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. , 1992, Chemical research in toxicology.

[80]  J. Gierthy,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[81]  B. Komm,et al.  Estrogen regulation of tissue-specific expression of complement C3. , 1989, The Journal of biological chemistry.

[82]  H. Rochefort,et al.  Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. , 1988, Nucleic acids research.

[83]  B. Katzenellenbogen,et al.  Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. , 1988, Endocrinology.

[84]  B. Katzenellenbogen,et al.  Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. , 1987, Cancer research.

[85]  H. Dickerman,et al.  Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells. , 1984, The Journal of biological chemistry.

[86]  I. Weinstein,et al.  Modification of deoxyribonucleic acid by a diol epoxide of benzo[a]pyrene. Relation to deoxyribonucleic acid structure and conformation and effects on transfectional activity. , 1979, Biochemistry.